Company: ZURA
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0001104659-25-038042
Chunk: 51

Company: Zura Bio Ltd
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 51
---
       — | ​ | ​ | ​ | ​                                      | ​ |   137,406 | ​ | ​ |
| Parvinder Thiara        | ​ | ​ | ​                                     | ​ |       — | ​ | ​ | ​ | ​                                      | ​ |   165,149 | ​ | ​ |
| Arnout Ploos van Amstel | ​ | ​ | ​                                     | ​ |       — | ​ | ​ | ​ | ​                                      | ​ |   165,149 | ​ | ​ |

Narrative to Director Compensation Table 2024 Director Compensation Program Each non-employee director received the following compensation for service on our Board in 2024: • an annual cash retainer of $50,000 (plus an additional $25,000 for the non-executive chair of our Board), which was reduced to $40,000, effective as of October 23, 2024; • an additional annual cash retainer of $8,000, $6,000 and $6,000 for service as a member of the Audit Committee, Compensation Committee and the Nominating and Governance Committee, respectively; • an additional annual cash retainer of $16,000, $12,000 and $10,000 for service as chair (in lieu of the additional annual cash retainer for services as a member) of the Audit Committee, Compensation Committee and the Nominating and Governance Committee, respectively;

30

TABLE OF CONTENTS • an initial option grant to purchase 48,149 of our Class A ordinary shares on the date of each such non-employee director’s appointment to our Board; and • an annual option grant to purchase 117,000 of our Class A ordinary shares on the date of each of our annual shareholder meetings. We also reimburse all of our non-employee directors for their reasonable out of pocket expenses incurred in attending Board and committee meetings. Each of the option grants described above were granted under our 2023 Plan. Each initial option grant will vest and become exercisable subject to the director’s continuous service to us through each of the first three anniversaries of the date of grant or the next annual shareholder meeting. Each annual option grant will vest and become exercisable subject to the director’s continuous service to us through the first anniversary of the date of grant. The term of each option will be ten years, subject to earlier termination as provided in our 2023 Plan. 2025 Director Compensation Program Our Board adopted a non-employee director compensation policy (“